Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/164715
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Fludarabine resistance mediated by aminoglycoside-3′-phosphotransferase-IIa and the structurally related eukaryotic cAMP-dependent protein kinase |
Autor: | Sánchez-Carrera, Damaso; Bravo-Navas, Sara; Cabezón, Elena CSIC ORCID; Arechaga, Ignacio CSIC ORCID; Cabezas, Matilde CSIC; Yáñez, Lucrecia; Pipaón, Carlos | Palabras clave: | Purine analogues FANC proteins DNA damage Protein kinase A |
Fecha de publicación: | 2017 | Editor: | Federation of American Societies for Experimental Biology | Citación: | FASEB Journal 31(7): 3007-3017 (2017) | Resumen: | While working with G418-resistant stably transfected cells, we realized the neomycin resistance (NeoR) gene, which encodes the aminoglycoside-3′-phosphotransferase-IIa [APH(3′)-IIa], also confers resistance to the nucleoside analog fludarabine. Fludarabine is a cytostatic drug widely used in the treatment of hematologic and solid tumors, as well as in the conditioning of patients before transplantation of hematopoietic progenitors. We present evidence that NeoR-transfected cells do not incorporate fludarabine, thus avoiding DNA damage caused by the drug, evidenced by a lack of FANCD2 monoubiquitination and impaired apoptosis. A screening of other nucleoside analogs revealed that APH(3′)-IIa only protects against ATP purine analogs. Moreover, APH(3′)-IIa ATPase activity is inhibited by fludarabine monophosphate, suggesting that APH(3′)-IIa blocks fludarabine incorporation into DNA by dephosphorylating its active fludarabine triphosphate form. Furthermore, overexpression of the catalytic subunit of the eukaryotic kinase PKA, which is structurally related to APHs, also provides resistance to fludarabine, anticipating its putative utility as a response marker to the drug. Our results preclude the use of Neo marker plasmids in the study of purine analogs and unveils a new resistance mechanism against these chemotherapeuticals. | URI: | http://hdl.handle.net/10261/164715 | DOI: | 10.1096/fj.201601245R | Identificadores: | doi: 10.1096/fj.201601245R e-issn: 1530-6860 issn: 0892-6638 |
Aparece en las colecciones: | (IBBTEC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
1
checked on 10-abr-2024
SCOPUSTM
Citations
1
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
1
checked on 23-feb-2024
Page view(s)
258
checked on 18-abr-2024
Download(s)
89
checked on 18-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.